1. Companies
  2. Kolltan Pharmaceuticals
  3. Team

  4. Team

Kolltan Pharmaceuticals

Kolltan Pharmaceuticals

Developing novel biologic drugs targeting receptor tyrosine kinases (RTKs) for oncology and immunology.
Launch date
Employees
2-10 people
Market cap
-
Enterprise valuation
$235m (Public information from Nov 2016)
New Haven Connecticut (HQ)
http://kolltan.com
https://twitter.com/arthurajrhttp://www.facebook.com/pages/Kolltan-Pharmaceuticals-Inc/193169757364347https://www.linkedin.com/company/kolltan-pharmaceuticals-inc.
Authorizing premium user...